Prevalence of renal disease within an urban HIV-infected cohort in northern Italy

Clinical and Experimental Nephrology

Volumn 18, Issue 1, 2014, Pages 104-112

  Calza, Leonardo ^a   Vanino, Elisa ^a   Magistrelli, Eleonora ^a   Salvadori, Caterina ^a   Cascavilla, Alessandra ^a   Colangeli, Vincenzo ^a   Di Bari, Maria Assunta ^a   Manfredi, Roberto ^a   Viale, Pierluigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Antiretroviral therapy; Glomerular disease; Renal dysfunction; Tenofovir; Tubular disease

Indexed keywords

ABACAVIR; ATAZANAVIR PLUS RITONAVIR; DARUNAVIR PLUS RITONAVIR; DIDANOSINE; LOPINAVIR PLUS RITONAVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; TENOFOVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPERTRIGLYCERIDEMIA; ITALY; KIDNEY DYSFUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDY; SEX DIFFERENCE; URBAN POPULATION; COMORBIDITY; HEALTH; HIV INFECTIONS; KIDNEY; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; TIME FACTOR;

ADULT; AGE FACTORS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; ITALY; KIDNEY; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; URBAN HEALTH;

EID: 84896717129     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-013-0817-5     Document Type: Article

References (26)

1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;388:853-60.
2. Palella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
3. Roling J, Schmid H, Fischereder M, et al. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis. 2006;42:1488-95.
4. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Disease Society of America. Clin Infect Dis. 2005;40:1559-85.
5. Miro JM, Cofan F, Trullas JC, et al. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep. 2012;9:187-99.
6. Medapalli RK, He JC, Klotman PE. HIV-associated nephropathy: pathogenesis. Curr Opin Nephrol Hypertens. 2011;20:306-11.
7. Kalayjian RC. Renal issues in HIV infection. Curr HIV/AIDS Rep. 2011;8:164-71.
8. Phair J, Palella F. Renal disease in HIV-infected individuals. Curr Opin HIV AIDS. 2011;6:285-9.
9. Maggi P, Bartolozzi D, Bonfanti P, et al. Renal complications in HIV disease: between present and future. AIDS Rev. 2012;14:37-53.
10. Calza L. Renal toxicity associated with antiretroviral therapy. HIV Clin Trials. 2012;13:189-211.
11. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-54.
12. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-266.
13. Mocroft A, Reiss P, Gasiorowski J, EuroSIDA Study Group, et al. Serious fatal and non-fatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr. 2010;55:262-70.
14. Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21:1119-27.
15. Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV-infected population. Am J Med Sci. 2008;335:89-94.
16. Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy K. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009;10:343-50.
17. Crum-Cianflone N, Ganesan A, Teneza-Mora N, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDs. 2010;24:353-60.
18. Mocroft A, Kirk O, Reiss P, EuroSIDA Study Group, et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24:1667-78.
19. Déti EK, Thiébaut R, Bonnet F, et al. Prevalence and factors associated with renal impairment in HIV-infected patients, ANRS C03 Aquitaine Cohort, France. HIV Med. 2010;11:308-17.
20. Rasch MG, Engsig FN, Feldt-Rasmussen B, et al. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study. Scand J Infect Dis. 2012;44:689-96.
21. Tordato F, Cozzi-Lepri A, Cicconi P, ICONA Foundation Study Group, et al. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med. 2011;12:4-13.
22. Jotwani V, Li Y, Grunfeld C, Choi AI, Shlipak MG. Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors. Am J Kidney Dis. 2012;59:628-35.
23. Medapalli R, Parikh CR, Gordon K, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr. 2012;60:393-9.
24. Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis. BMC Public Health. 2012;12:234.
25. Calza L, Trapani F, Tedeschi S, et al. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients. Scand J Infect Dis. 2011;43:656-60.
26. Calza L, Trapani F, Salvadori C, et al. Incidence of renal toxicity in HIV-infected, antiretroviral-naïve patients starting tenofovir/ emtricitabine associated with efavirenz, atazanavir/ritonavir or lopinavir/ritonavir. Scand J Infect Dis. 2013;45:147-54.